GATC Health
Accurate, Personalized, and Predictive Insights into Human Biology

The healthcare industry is on a constant pursuit to provide more accurate, precise, proactive, and impactful care for each individual patient. Advances in biotechnology are making this mission a reality and redefining how modern physicians and scientists identify, assess, and combat threats to health and wellness. In such a scenario, precision medicine has emerged as a promising approach for disease treatment and prevention. While traditional medical care is reactive and non-specific, based on generalities and estimated outcomes, precision medicine is specific, personalized, and predictive. One company that is at the forefront of the new medicine arena is GATC Health, a pioneering technology company that is on a mission to leverage individualized genetic data to help predict risks and treatment outcomes, and provide precision medicine that is tailored to each patient’s unique needs. GATC Health helps develop personalized medical analysis and reporting for disease risk, tolerance, complications, and preventions. In addition, the company helps fast-track drug discovery and repurposing.

“With the most insightful AI platform in biotech, we are uniquely capable of analyzing human biology to address complex physiological issues,” explains Jeff Moses, CMO, GATC Health. The company’s Multiomic Advanced Technology™ (MAT) platform utilizes advanced artificial intelligence to analyze comprehensive biological datasets (multiomics) to yield the most comprehensive, predictive health analysis available. From these insights, GATC Health can identify ways to greatly reduce or mitigate health risks before they manifest. Multiomics is the study of all the molecules in the human body that contribute to or define biological processes. This includes genomics, proteomics, microbiomics, and metabolomics.

We are uniquely capable of analyzing human biology and addressing complex physiological issues

Since the human body is comprised of multiple biological systems that are interdependent, using data collected from only one omic, for instance, genomics is not optimal. By taking into account multiomic data, MAT can essentially create a digital human which helps understand what the targets are for certain disease states and how biomarkers work in that context, thus providing deep insights into human biology.

Initially, the time taken to analyze the multiomic dataset of an individual took about 165 hours. Today, the same can be completed in under five minutes and in parallel with millions of datasets due to GATC Health’s ability to process data increasing exponentially over the years. GATC Health can make very accurate predictions about health risks to a specific disease state very early. GATC Health is collaborating with leading diabetes researchers in the world to extend the honeymoon period for diabetes by 10-15 years through early disease identification and suggesting proper interventions. Earlier detection will help suggest proper interventions primarily lifestyle changes to stave of the rapid decline of a patient once the disease is triggered.

Moses mentions GATC Health’s partnership with Liquid Biosciences, a healthcare company that was investigating the cause of cocaine addiction or stimulant addiction in general. GATC Health was able to illuminate the biological pathways the client had identified prior in less than eight weeks. GATC Health also discovered three new molecules that the company will be the basis for the treatment of stimulant addiction. These developments have high potential to solve an issue where many others have failed previously.

Currently, GATC Health offers diagnostic products that include viral immunity, health and wellness, depression and anxiety, and medical cannabis. The company plans to launch its diagnostic products for diabetes and cardiac risk in the very near future. GATC Health is also in a period of phenomenal growth with a very deep pipeline of projects both internally and through partners. The company is working on refining its platform to reduce millions of man-hours of clinical work down to days of data processing. GATC Health is committed to accelerating the work of labs, pharmaceuticals, and clinics through its AI-enabled multiomic analysis approach.